Navigation Links
Naltrexone also Treats Crohn's Disease

A study by Penn State College of Medicine finds that naltrexone may be beneficial to people with Crohn's disease. A low dose of this drug is often used to bring// relief to victims of alcohol and drug addiction.

Crohn’s disease is a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans. The study results were released online this week in an early edition of the American Journal of Gastroenterology.

A team of researchers led by gastroenterologist Jill P. Smith, M.D., and Ian S. Zagon, Ph.D., Distinguished Professor of neural and behavioral sciences, at the College of Medicine and Penn State Milton S. Hershey Medical Center, received NIH funding last summer to initiate a phase 2 trial of low-dose naltrexone and Crohn's.

In the pilot study, patients with diagnosed Crohn's disease were treated with a low dose of naltrexone and monitored for improvement of symptoms for 12 weeks. Quality of life surveys were given every four weeks for 16 weeks. The results, published this week, show that 89 percent of participants showed an improvement with therapy, while 67 percent achieved remission of symptoms. The only side effect to treatment was sleep disturbance in some patients.

Typical treatment for Crohn's involves using steroids or corticosteroids, which suppress the immune system and can have other toxic side effects. Treatment is often time-intensive and expensive, as well.

'This is a novel approach to treating a common disease, and it's simple, it's safe, and it costs far less than current standards of treatment,' Smith said. 'We don't yet know the exact mechanisms involved in how it works, but we're working on that, as well.'

Source-Eurekalert
PRI
'"/>




Page: 1

Related medicine news :

1. Naltrexone effective for drinking problems
2. Naltrexone Packs a Punch for Women Smokers Who Wish to Quit
3. Anti-Craving Drug, Naltrexone Helps Women Quit Smoking
4. Cyclosporin A Treats Leukemia Complications
5. Weight Reduction Surgery Also Treats Metabolic Syndrome
6. Chennai Hospital Treats Pakistani Blue Baby
7. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
8. New Gene Therapy Treats Diabetic Neuropathy
9. Actonel Treats Hip Fractures In A Better Way Than Alendronate
10. BBIC – A SOY-based Substance Treats Multiple Sclerosi
11. Cake Walk – Plum Treats Sell Like Hot Cakes During Christma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel of ... of proceeds to two local organizations: North Chicago Animal Control and Friends and Our ... a team of authorized and trained volunteers who support rescued animals held in the ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies and ... scam operations to a halt. According to Texas Premier Locksmith, these fraudulent locksmith ...
(Date:12/7/2016)... CA (PRWEB) , ... December 07, 2016 , ... The ... the holidays and winter seasons. One major study analyzing heart attacks among 138,602 ... to August of a given year. We would all agree of course–no time of ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen ... Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years ... three acupuncturists to help patients realize their family building goals. Acupuncture helps ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- KEY FINDINGS Patient warming and ... loss of blood during surgeries, lowering the risks ... after surgeries, and decreasing risks of SSIs. The ... warming system, surface warming systems, and intravascular warming ... at hospitals thus, lowering the healthcare costs by ...
(Date:12/7/2016)... 7, 2016 Research and Markets has announced ... User - Global Forecast to 2021" report to their offering. ... , , ... by 2021, growing at a CAGR of 7.3% during the forecast period ... prevalence of cancer and rapidly increasing geriatric population across the globe are ...
(Date:12/7/2016)... Dec. 7, 2016 DelveInsight,s, "Janus ... provides in depth insights on the pipeline ... Janus Kinase 3 (JAK3) Inhibitors. The DelveInsight,s ... stages of development including Discovery, Pre-clinical, IND, ... Preregistration. Report covers the product clinical trials ...
Breaking Medicine Technology: